期刊文献+

血清降钙素原对恶性血液病化疗后粒缺感染后抗生素使用的指导意义

下载PDF
导出
摘要 目的探讨动态监测血清降钙素原(PCT)对指导恶性血液病化疗后粒缺感染患者抗生素使用的临床价值。方法选取91例恶性血液病化疗后粒缺感染的患者,随机分为PCT监测治疗组(45例,PCT组)和常规治疗组(46例,对照组)。相同的诊疗基础上,对照组根据抗生素应用指南决定疗程。PCT组根据血清PCT检测值判断是否继续或停止使用抗生素,当血清PCT≥0.25ng·m L^(-1)时,进行抗生素治疗;PCT<0.25ng·m L^(-1)时,停止抗生素治疗。结果 PCT组抗生素疗程8~15d,平均(12.35±2.47)d;对照组抗生素疗程11~19d,平均(15.78±2.69)d;PCT组患者抗生素疗程明显少于对照组(P<0.05)。两组病例治愈率,好转率,死亡率相当,无统计学差异(P>0.05)。结论恶性血液病化疗后粒缺感染患者根据PCT使用抗生素,能够缩短抗生素疗程,减少住院天数,动态监测PCT水平可作为优化抗生素治疗的有效指标。
出处 《海峡药学》 2016年第6期149-150,共2页 Strait Pharmaceutical Journal
基金 丽水市科技局公益项目(编号:2014GYX035)
  • 相关文献

参考文献6

  • 1Walkty A,De Corby M,Nichol K,et al.Antimicrobial susceptibility ofpseudomonas aeruginosa iso1ates obtained from patients in canadian intensive care units as part of the canadian national intensive care unitstudy[J].Diagn Microbiol Infect Dis,2008,62:217-221.
  • 21.Fey M,Dreyling M:ESMO Guidelines Working Group:Acute myeloblastic leukemia in adult patients:ESMO clinical recommendations for diagnosis,treatment and follow-up[J].Ann oncol,2008,19 suppl 2:ii58.
  • 32.Buck BH,Liebeskind DS,Saver JL,et al:Early neutrophilia is associated with volume of ischemic tissue in acute stroke[J].Stroke,2008,39:355.
  • 4张翼,余刚.降钙素原在颅内感染中的临床应用研究进展[J].中国全科医学,2012,15(24):2732-2734. 被引量:36
  • 5Petros S,Leonhardt U,Engelmann L.Serum procalcitoninand proinflammatory cytokines a patient with acute severeleptospirosis[J].Scand J Infect Dis,2000,32(1):104-105.
  • 6Christ-Crain M,Stolz D,Bingisser R,et al.Procalcitoninguidance of antibiotic therapy in community-acquiredpneumonia:a randomized trial[J].Am J Respir Crit Care Med,2006,174(1):84-93.

二级参考文献26

  • 1苏卫东,瞿尔力,黄育丹,陈清,包曼华.降钙素原在诊断新生儿感染中的应用价值[J].中华围产医学杂志,2006,9(1):21-23. 被引量:12
  • 2Assicot M,Gendrel D,Carsin H,et al.High serum procalcitonin concentrations in patients with sepsis and infection[J].Lancet,1993,341(8844):515-518.
  • 3Nylen ES,Whang KT,Snider RH Jr,et al.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[J].Crit Care Med,1998,26(6):1001-1006.
  • 4Whang KT,Vath SD,Becker KL,et al.Procalcitqnin and proinflam matory cytokine interaction in sepsis[J].Shock,2000,l4(1):73-78.
  • 5Casad-Flores J,Blanco-Quirós A,Asensio J,et al.Serum procalcintonin in children with suspected sepsis:a comparison with C-reactive protein and neutrophil count[J].Pediatr Crit Care Med,2003,4(2):190-195.
  • 6Barati M,Alinejad F,Bahar MA,et al.Comparison of WBC,ESR,CRP and PCT serum levels in septic and non-septic burn cases[J].Burns,2008,34(6):770-774.
  • 7Alkholi UM,Abd Al-Monem N,Abd El-Azim AA,et al.Serum procalcitonin in viral and bacterial meningitis[J].J Glob Infect Dis,2011,3(1):14-18.
  • 8Viallon A,Guyomarc′h P,Guyomarc′h S,et al.Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis[J].Crit Care,2005,9(4):R344-R350.
  • 9Jereb M,Muzlovic I,Hojker S,et al.Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnisis of bacteral meningitis[J].Infection,2001,29(4):209-212.
  • 10Lorrot M,Moulin F,Coste J,et al.Procalcitonin in pediatric emergendes:comparison with C-reactive protein,interleukin-6 and interferon alpha in the differentiation between bacteria and vir Infections[J].Press Med,2000,29(3):128-134.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部